FDA Approved: PLERIXAFOR — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves a supplemental application for Plerixafor submitted by Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)